Australia’s TGA published updated regulatory guidelines for biologicals. The new framework contains pathways for the supply of biologicals that reiterates the basics of therapeutic goods regulation, but includes: ● new guidance on classification of biologicals ● a step-by-step guide on applying for inclusion of a Class 2, 3 or 4 biological (cell/tissue products), and ● post-market responsibilities.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
